news – Page 5626 – pharmaceutical daily

March 8, 2017 Off

IntegraGen and Laboratoire CERBA join forces to fight colorectal cancer

IntegraGen SA, a company specializing in the decoding of the human genome and performing interpretable genomic tests for academic and private laboratories and a developer of diagnostic tools in oncology, and Laboratoire CERBA, has signed a licensing agreement allowing Laboratoire CERBA to develop and provide to prescribing clinicians a test based on IntegraGen’s proprietary miR-31-3p biomarker.

March 8, 2017 Off

Esperite in €1million private placement

By Dino Mustafić

Esperite N.V. has announced a €1 million private placement of 100 convertible notes with a principal amount of €10,000 each, with share subscription warrants attached (the “First Tranche Notes and Warrants”).

March 8, 2017 Off

Alexion waits for FDA’s OK for generalized myasthenia gravis drug

By Dino Mustafić

U.S. Food and Drug Administration(FDA) has accepted for review the Alexion Pharmaceuticals’s supplemental Biologics License Application (sBLA) to extend the indication for Soliris (eculizumab) as a potential treatment for patients with refractory generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody-positive.

March 8, 2017 Off

New CFO for InDex Pharmaceuticals Holding

By Dino Mustafić

InDex Pharmaceuticals Holding AB has appointed Johan Giléus as new Chief Financial Officer (CFO) who will take over his new duties from May 1, 2017.

March 8, 2017 Off

Ceylad to enrol patients for THINK trial in USA

By Dino Mustafić

Celyad is about to kick the THINK trial in the USA, after the U.S. FDA authorized its initiation. THINK evaluates NKR-2 CAR-T cells in seven indications, five solid cancers and two hematological malignancies.

March 8, 2017 Off

OptiBiotix in a deal with manufacturing and profit sharing deal with Sacco, international plans for LPLDL

By Dino Mustafić

OptiBiotix health has signed a manufacturing, supply, and profit sharing deal with Sacco, one of Europe’s leading suppliers of probiotics ingredients.

March 8, 2017 Off

ValiSeek adding third trial site in Georgia

By Dino Mustafić

Valisek, a joint venture between ValiRx, a clinical stage biotechnology company and Tangent Reprofiling Limited, plans to add a third clinical site, in Tbilisi, Georgia.

March 7, 2017 Off

Biotech, pharma stocks rise driven by acquisitions and new products

By Dino Mustafić

Notable news in the pharmaceutical and biotech markets includes a slew of mergers and acquisitions, new drug trails and product launches as industry leaders search for competitive advantage and increased revenue streams.

March 7, 2017 Off

Innate Pharma reports €12,6M profit for 2016

By Dino Mustafić

Innate Pharma has reported its consolidated financial results for the year ended December 31, 2016.

March 7, 2017 Off

Increased shelf life and extended out-of-refrigeration for Sobi’s Orafidin

By Dino Mustafić

Swedish Orphan Biovitrum AB known as Sobi said Tuesday that the FDA has approved increased shelf life and extended out-of-refrigeration for Orfadin capsules.